DNA-Repair Gene Mutations in Metastatic Prostate Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

24 citing papers in PubMed.

1. Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study.Cancer · 2026
   Article
2. CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer.Pharmaceuticals (Basel, Switzerland) · 2024
   Review
3. Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer.European urology oncology · 2024
   Article
4. Prostate cancer genotyping for risk stratification and precision treatment.Current urology · 2024
   Review
5. Fourier-transform infrared spectroscopy for typing of vancomycin-resistantMicrobiology spectrum · 2023
   Article
6. Germline Variants in DNA Damage Repair Genes andJCO precision oncology · 2022
   Article
7. Prostate cancer in omics era.Cancer cell international · 2022
   Article
8. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.European urology · 2022
   Article
9. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.International journal of molecular sciences · 2021
   Review
10. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.The Prostate · 2021
    Article
11. Prostate cancer.Nature reviews. Disease primers · 2021
    Review
12. [Systemic treatment of advanced prostate cancer].Der Urologe. Ausg. A · 2020
    Review
13. Targeting DNA Damage Response in Prostate and Breast Cancer.International journal of molecular sciences · 2020
    Review
14. The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2020
    Article
15. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Article
16. PARP inhibitor combinations in prostate cancer.Therapeutic advances in medical oncology · 2020
    Review
17. Clinical implications of mismatch repair deficiency in prostate cancer.Future oncology (London, England) · 2019
    Review
18. The influence of BRCA2 mutation on localized prostate cancer.Nature reviews. Urology · 2019
    Review
19. DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features.Histopathology · 2019
    Article
20. Differential impact of RB status on E2F1 reprogramming in human cancer.The Journal of clinical investigation · 2018
    Article

Corrections and comments

• Comment on
  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.2016
• Comment on
  DNA-Repair Gene Mutations in Metastatic Prostate Cancer.2016
• Comment on
  DNA-Repair Gene Mutations in Metastatic Prostate Cancer.2016
• Comment on
  DNA-Repair Gene Mutations in Metastatic Prostate Cancer.2016

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as